DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Farletuzumab
Farletuzumab
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
Consideration Toward Safety Guidance for Targeted Alpha Therapy in Japan
2017 Immuno-Oncology Medicines in Development
The Two Tontti Tudiul Lui Hi Ha Unit
(12) Patent Application Publication (10) Pub. No.: US 2015/0250896 A1 Zhao (43) Pub
NSCLC Therapeutics in Asia-Pacific Markets to 2019 Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool
(INN) for Biological and Biotechnological Substances
Ep 3321281 A1
PANI: a Novel Algorithm for Fast Discovery of Putative Target Nodes in Signaling Networks
Prescrire's Response
WO 2014/197854 Al 11 December 2014 (11.12.2014) P O P C T
Antibody–Drug Conjugates for Cancer Therapy
INN Working Document 05.179 Update 2011
Stembook 2018.Pdf
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
2018 Medicines in Development for Cancer
(12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
Top View
Drug-Based Optical Agents: Infiltrating Clinics at Lower Risk
(INN) for Biological and Biotechnological Substances
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
Monoclonal Antibody Pharmacogenomics in Cancer Treatment
Farletuzumab for Ovarian Cancer
A61K9/51 (2006.01) — with International Search Report (Art
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Farletuzumab, a Humanized Monoclonal Antibody Against Folate Receptor Α, in Epithelial Ovarian Cancer: a Phase I Study
( 12 ) United States Patent ( 10 ) Patent No .: US 10,906,990 B2 Sakamoto Et Al
Assessment of the Evolution of Cancer Treatment Therapies
NCI-SNMMI Workshop on Targeted Radionuclide Therapy
Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: the “Hopeful Eight”
Antibody-Drug Conjugate (Adc) and Method for Forming the Same
(12) United States Patent (10) Patent No.: US 9.295,731 B2 Nguyen (45) Date of Patent: Mar
Hassan, R CV 9 18 14
Antibody Therapy of Cancer
Targeted Radionuclide Therapy: Proceedings of the 2Nd NCI-SNMMI Workshop On
Supplementary Tables and Figures Section 1. Distribution of CDR-H3
Breast Cancer Cancer Drug Pipeline Information for Patient Advocacy
Oncology Drugs in the Pipeline
Orphan Drug Designations and Approvals List As of 06‐01‐2015 Governs July 1, 2015 ‐ September 30, 2015
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
In Oncology Lacey R
Morab-202, an Antibody–Drug Conjugate Utilizing Humanized Anti
Protein-Polymer-Drug Conjugates Protein-Polymer-Wirkstoffkonjugate Conjugués De Médicament-Protéine-Polymère
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Narrative Review of Novel Chemotherapeutic Agents in Management of Ovarian Cancer
Cancer PRESENTEDBYAMERICA ’ SBIOPHARMACEUTICALRESEARCHCOMPANIES Nearly 900 Medicines and Vaccines in Testing Offer Hope in the Fight Against Cancer
(INN) for Biological and Biotechnological Substances
Medicines & Vaccines in Development for Cancer
Which Are the Antibodies to Watch in 2012?
Ep 3088005 A1
Assessment of the Evolution of Cancer Treatment Therapies
Recommended INN: List 62
Timepoint 1 Geting Assembly Complexes (Attacs) for Selectively Activating De¬ Sired Immune Cells in the Tumor Microenvironment
| Hai Laila a Et Antaloni Di Atas Tu
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Antibody-Drug Conjugates: a Promising Novel Therapy for the Treatment of Ovarian Cancer
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri